Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2011 (Vol. 31, No. 1)

Solving the Antithrombotic Conundrum

Selective and Reversible Inhibition of Clotting Cascade Yields Safer, More Effective Therapies

  • The multibillion-dollar worldwide market for injectable antithrombotic drugs (including anticoagulants and antiplatelet agents) will continue to grow as minimally invasive surgical interventions to open blocked coronary vessels become increasingly commonplace. Despite the agents available in the clinician’s antithrombotic toolbox today, control of clotting remains suboptimal. Clinicians performing intravascular ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.